Arcturus Engineering, Inc.

Breakthroughs in molecular biology have greatly expanded our understanding of the structure, function, and development of cells, organs, and organisms. With the completion of the sequencing of the human genome, scientists are now exploring the functions each gene controls, how it regulates these functions, and how genetic aberrations result in disease. Over the next decade, these new insights from basic science will be applied directly to critical human health care issues. New drugs and diagnostic procedures will directly target the molecular changes that characterize and give rise to disease, radically altering medical diagnosis and treatment. This medical revolution will stimulate dramatic growth in medical diagnostics and require a new generation of instruments, disposable components, reagents, and software tools.

Arcturus was founded in 1996 with the mission to design innovative technology that will stimulate the development of these new molecular diagnostic methodologies, and to promote their rapid implementation in clinical practice. The Arcturus team includes experienced senior management, multidisciplinary instrument engineering and life science product development groups, an Applied Genomics research group, and a worldwide marketing and sales network. Its products have been enthusiastically accepted by the medical research community, with installations worldwide. Arcturus has a solid intellectual property position in the molecular diagnostics area, as well as research and development collaborations with pharmaceutical companies, government medical research laboratories, and universities. These focus on developing instruments, disposables, and reagents that will form the basis of a technology platform suitable for life science research, cancer screening and diagnosis, as well as supplying critical tools for new drug development.